Tilray Brands(NASDAQ) TLRY

Tilray Brands, Inc. sells cannabis, craft beer, and wellness products. It helps patients find medicine and adults enjoy drinks and foods. The company serves global customers through pharmacies and retail stores.

What Does Tilray Sell?

• Beverage Alcohol: Craft beers, spirits, and non-alcoholic drinks sold through retail channels and 20 brew pubs; generated $101.5 million in net revenue for the three months ended Aug. 31, 2026.
• Cannabis Products: Medical and recreational cannabis items, including flowers, oils, and edibles; generated $56.1 million in net revenue for the three months ended Aug. 31, 2026.
• Distribution Services: Purchase and resale of pharmaceutical and wellness goods across Germany and other international markets; generated $84.3 million in net revenue for the three months ended Aug. 31, 2026.
• Wellness Items: Hemp-derived foods and natural energy drinks; generated $15.3 million in net revenue for the three months ended Aug. 31, 2026.

Expanding the Global Reach

• Acquired BrewDog's global business in early 2026 to transform into a global beverage platform with infrastructure in the United States and United Kingdom.
• Purchased Lyphe, a medical cannabis clinic and digital pharmacy platform in the United Kingdom, on April 15, 2026.
• Entered a licensing agreement with Carlsberg Group in Feb. 2026 to produce and sell several beer brands in the United States starting in Jan. 2027.
• Acquired HelloMD in July 2026 to expand direct-to-patient medical cannabis services in Canada.

The Production and Supply Network

Tilray manages its own production through specialized facilities in Portugal and Germany to ensure quality for international medical markets. The company uses its distribution networks to move pharmaceutical and wellness products across Europe and other regions.

The Financial Scorecard

• Net revenue reached $257.1 million for the three months ended Aug. 31, 2026, up 23% year over year.
• Gross profit rose to $77.5 million for the three months ended Aug. 31, 2026, up 35% year over year.
• The company reported a net loss of $40.0 million for the three months ended Aug. 31, 2026, compared to a net income of $1.5 million in the prior year period.
• Adjusted EBITDA was $9.2 million for the three months ended Aug. 31, 2026, down 10% year over year.
• Cash, cash equivalents, and marketable securities totaled $221.4 million as of Aug. 31, 2026.

Evolution of the Brand

Tilray has shifted from a cannabis-focused firm into a diversified consumer goods company with interests in beverages and wellness. Its expansion into global markets supports its effort to grow beyond the Canadian cannabis sector.